1. Home
  2. CDNA vs OSPN Comparison

CDNA vs OSPN Comparison

Compare CDNA & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • OSPN
  • Stock Information
  • Founded
  • CDNA 1998
  • OSPN 1991
  • Country
  • CDNA United States
  • OSPN United States
  • Employees
  • CDNA N/A
  • OSPN N/A
  • Industry
  • CDNA Medical Specialities
  • OSPN EDP Services
  • Sector
  • CDNA Health Care
  • OSPN Technology
  • Exchange
  • CDNA Nasdaq
  • OSPN Nasdaq
  • Market Cap
  • CDNA 712.2M
  • OSPN 612.8M
  • IPO Year
  • CDNA 2014
  • OSPN 1998
  • Fundamental
  • Price
  • CDNA $14.45
  • OSPN $15.12
  • Analyst Decision
  • CDNA Buy
  • OSPN Strong Buy
  • Analyst Count
  • CDNA 8
  • OSPN 3
  • Target Price
  • CDNA $26.86
  • OSPN $19.67
  • AVG Volume (30 Days)
  • CDNA 1.3M
  • OSPN 334.9K
  • Earning Date
  • CDNA 11-03-2025
  • OSPN 10-30-2025
  • Dividend Yield
  • CDNA N/A
  • OSPN 3.14%
  • EPS Growth
  • CDNA N/A
  • OSPN 265.73
  • EPS
  • CDNA 1.00
  • OSPN 1.53
  • Revenue
  • CDNA $340,826,000.00
  • OSPN $240,621,000.00
  • Revenue This Year
  • CDNA $12.73
  • OSPN $3.97
  • Revenue Next Year
  • CDNA $11.90
  • OSPN $5.44
  • P/E Ratio
  • CDNA $14.57
  • OSPN $10.00
  • Revenue Growth
  • CDNA 14.72
  • OSPN N/A
  • 52 Week Low
  • CDNA $10.96
  • OSPN $12.51
  • 52 Week High
  • CDNA $31.52
  • OSPN $20.37
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 50.12
  • OSPN 44.36
  • Support Level
  • CDNA $13.95
  • OSPN $14.95
  • Resistance Level
  • CDNA $15.50
  • OSPN $15.82
  • Average True Range (ATR)
  • CDNA 0.55
  • OSPN 0.41
  • MACD
  • CDNA -0.10
  • OSPN -0.13
  • Stochastic Oscillator
  • CDNA 32.26
  • OSPN 11.64

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

Share on Social Networks: